Author Page
David A. Chorney
Contributor's Topics
Email  |  Website  |  Biography  |  Articles
Contact details for
Mintz
Tel: +1 617 5426000
Fax: +1 617 5422241
One Financial Center
Boston
MA 02111
United States
In June 2019, the Delaware Supreme Court issued a decision reaffirming director liability where there is no board-level reporting process for essential compliance matters.
As predicted by our colleagues earlier this month, outgoing Commissioner Scott Gottlieb of the U.S. Food and Drug Administration (FDA) released a comprehensive press release.
As any medical product business knows, compliance with the AdvaMed Code of Ethics (the "Code") is essential.
The U.S. Department of Health and Human Services, Office for Civil Rights recently announced a no-fault settlement, including a $125,000 penalty and a two year corrective action plan for Allergy Associates of Hartford, P.C.
Below is a summary of the significant impacts on the Section 1332 Waiver process.
Getting Headlines
Based on Mondaq users readership, this author is ranked as Very Popular in United States for the topics, user groups and industry sectors listed below:
Position
  • Corporate/Company Secretary, Compliance Officer
  • Banker, Stockbroker, Analyst, Economist
  • Inhouse Counsel, Lawyer in Company/Government
  • CEO, Owner, Chairman, President, Mng Director
    • Industry
  • Utilities
  • Pharmaceuticals & BioTech
  • Securities & Investment
  • Property
  • Telecomms
    • * Rankings are based on analysis of the last 12 months of Mondaq readership data across more than 25,000 contributing authors. To be ranked ‘Very Popular’ an author must be in the top 20% of results within the selected criteria.
    More...
     
    News Alert| Login| Register